CN115747208A - 一种dna/rna混合物的处理方法 - Google Patents
一种dna/rna混合物的处理方法 Download PDFInfo
- Publication number
- CN115747208A CN115747208A CN202211526565.4A CN202211526565A CN115747208A CN 115747208 A CN115747208 A CN 115747208A CN 202211526565 A CN202211526565 A CN 202211526565A CN 115747208 A CN115747208 A CN 115747208A
- Authority
- CN
- China
- Prior art keywords
- dna
- rna
- sample
- nucleic acid
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 82
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 238000012545 processing Methods 0.000 title description 2
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 41
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 34
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 34
- 239000000523 sample Substances 0.000 claims description 54
- 238000012163 sequencing technique Methods 0.000 claims description 32
- 238000010839 reverse transcription Methods 0.000 claims description 25
- 238000010276 construction Methods 0.000 claims description 16
- 108010020764 Transposases Proteins 0.000 claims description 15
- 102000008579 Transposases Human genes 0.000 claims description 15
- 239000011324 bead Substances 0.000 claims description 14
- 239000002299 complementary DNA Substances 0.000 claims description 12
- 230000029087 digestion Effects 0.000 claims description 11
- 244000000010 microbial pathogen Species 0.000 claims description 10
- 238000006062 fragmentation reaction Methods 0.000 claims description 9
- 108010012306 Tn5 transposase Proteins 0.000 claims description 8
- 108010042407 Endonucleases Proteins 0.000 claims description 7
- 238000000658 coextraction Methods 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 6
- 101710163270 Nuclease Proteins 0.000 claims description 5
- 238000010297 mechanical methods and process Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 4
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 206010036790 Productive cough Diseases 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 238000006911 enzymatic reaction Methods 0.000 claims description 3
- 210000003802 sputum Anatomy 0.000 claims description 3
- 208000024794 sputum Diseases 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229930024421 Adenine Natural products 0.000 claims description 2
- 241000606161 Chlamydia Species 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 241000204031 Mycoplasma Species 0.000 claims description 2
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 208000002151 Pleural effusion Diseases 0.000 claims description 2
- 102000029797 Prion Human genes 0.000 claims description 2
- 108091000054 Prion Proteins 0.000 claims description 2
- 241000606701 Rickettsia Species 0.000 claims description 2
- 241000589970 Spirochaetales Species 0.000 claims description 2
- 229960000643 adenine Drugs 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 2
- 239000005547 deoxyribonucleotide Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 244000045947 parasite Species 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 102000004533 Endonucleases Human genes 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 37
- 244000052769 pathogen Species 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 128
- 238000006243 chemical reaction Methods 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 10
- 238000010348 incorporation Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 102100031780 Endonuclease Human genes 0.000 description 6
- 238000013467 fragmentation Methods 0.000 description 6
- 241000219194 Arabidopsis Species 0.000 description 5
- 102100034343 Integrase Human genes 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012264 purified product Substances 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000011176 pooling Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000222173 Candida parapsilosis Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 241000046923 Human bocavirus Species 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000484121 Human parvovirus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 241000700560 Molluscum contagiosum virus Species 0.000 description 1
- 241001508003 Mycobacterium abscessus Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241000233870 Pneumocystis Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000960387 Torque teno virus Species 0.000 description 1
- 241000711975 Vesicular stomatitis virus Species 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 229940055022 candida parapsilosis Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 201000003486 coccidioidomycosis Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 108010002712 deoxyribonuclease II Proteins 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 201000000317 pneumocystosis Diseases 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (25)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311000340.XA CN117025723A (zh) | 2022-11-14 | 2022-12-01 | 一种dna/rna混合物的处理方法 |
PCT/CN2023/130063 WO2024104216A1 (zh) | 2022-11-14 | 2023-11-07 | 一种dna和rna混合物的处理方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211421219 | 2022-11-14 | ||
CN202211421219X | 2022-11-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311000340.XA Division CN117025723A (zh) | 2022-11-14 | 2022-12-01 | 一种dna/rna混合物的处理方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115747208A true CN115747208A (zh) | 2023-03-07 |
CN115747208B CN115747208B (zh) | 2023-08-29 |
Family
ID=85341797
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211526565.4A Active CN115747208B (zh) | 2022-11-14 | 2022-12-01 | 一种dna/rna混合物的处理方法 |
CN202311000340.XA Pending CN117025723A (zh) | 2022-11-14 | 2022-12-01 | 一种dna/rna混合物的处理方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311000340.XA Pending CN117025723A (zh) | 2022-11-14 | 2022-12-01 | 一种dna/rna混合物的处理方法 |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN115747208B (zh) |
WO (1) | WO2024104216A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024104216A1 (zh) * | 2022-11-14 | 2024-05-23 | 南京诺唯赞生物科技股份有限公司 | 一种dna和rna混合物的处理方法 |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180002749A1 (en) * | 2016-06-30 | 2018-01-04 | Grail, Inc. | Differential tagging of rna for preparation of a cell-free dna/rna sequencing library |
CN110093455A (zh) * | 2019-04-27 | 2019-08-06 | 中国医学科学院病原生物学研究所 | 一种呼吸道病毒的检测方法 |
CN111139532A (zh) * | 2020-02-24 | 2020-05-12 | 南京诺唯赞生物科技有限公司 | 一种dna和rna同时构建测序文库的方法及试剂盒 |
US20200149036A1 (en) * | 2017-01-02 | 2020-05-14 | Exosome Diagnostics, Inc. | Methods to distinguish rna and dna in a combined preparation |
CN111188094A (zh) * | 2020-02-24 | 2020-05-22 | 南京诺唯赞生物科技有限公司 | 一种用于病原微生物检测的测序文库构建方法和试剂盒 |
WO2020142153A1 (en) * | 2018-12-31 | 2020-07-09 | Htg Molecular Diagnostics, Inc. | Methods of detecting dna and rna in the same sample |
CN111471676A (zh) * | 2020-03-13 | 2020-07-31 | 广州市达瑞生物技术股份有限公司 | 一种宏基因组二代测序的建库样本的制备方法 |
CN112011596A (zh) * | 2020-09-11 | 2020-12-01 | 深圳华大因源医药科技有限公司 | 一种同时检测多种微生物基因组的方法、溶液和试剂盒 |
CN112011835A (zh) * | 2020-10-22 | 2020-12-01 | 南京实践医学检验有限公司 | 一种病原微生物检测用测序文库的构建方法 |
CN112176420A (zh) * | 2020-09-15 | 2021-01-05 | 上海英基生物科技有限公司 | 一种dna和rna共建库的方法及试剂盒 |
CN112195521A (zh) * | 2020-09-11 | 2021-01-08 | 翌圣生物科技(上海)有限公司 | 一种基于转座酶的dna/rna共建库方法、试剂盒及应用 |
CN112226488A (zh) * | 2020-10-13 | 2021-01-15 | 上海宝藤生物医药科技股份有限公司 | 一种基于总核酸和宏基因组学构建病原微生物测序文库的方法及试剂盒 |
CN112646859A (zh) * | 2020-12-30 | 2021-04-13 | 中国人民解放军疾病预防控制中心 | 一种基于宏基因组学的呼吸道咽拭子样本的建库方法和病原检测方法 |
CN112680795A (zh) * | 2020-12-29 | 2021-04-20 | 上海派森诺生物科技股份有限公司 | 一种mNGS法检测病原微生物的DNA文库构建方法 |
CN113215235A (zh) * | 2021-06-17 | 2021-08-06 | 嘉兴允英医学检验有限公司 | 一种高通量快速检测病原微生物的方法 |
CN113249439A (zh) * | 2021-05-11 | 2021-08-13 | 杭州圣庭医疗科技有限公司 | 一种简化dna甲基化文库及转录组共测序文库的构建方法 |
CN113355390A (zh) * | 2021-06-04 | 2021-09-07 | 翌圣生物科技(上海)股份有限公司 | 可区分dna和rna来源的共建库方法 |
CN113684249A (zh) * | 2021-08-25 | 2021-11-23 | 广州达安基因股份有限公司 | 一种rna和dna二代测序文库的构建方法及二代测序盒 |
CN114075596A (zh) * | 2020-08-12 | 2022-02-22 | 深圳华大因源医药科技有限公司 | 一种基于高通量测序技术检测目的微生物基因组rna的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115747208B (zh) * | 2022-11-14 | 2023-08-29 | 南京诺唯赞生物科技股份有限公司 | 一种dna/rna混合物的处理方法 |
-
2022
- 2022-12-01 CN CN202211526565.4A patent/CN115747208B/zh active Active
- 2022-12-01 CN CN202311000340.XA patent/CN117025723A/zh active Pending
-
2023
- 2023-11-07 WO PCT/CN2023/130063 patent/WO2024104216A1/zh unknown
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180002749A1 (en) * | 2016-06-30 | 2018-01-04 | Grail, Inc. | Differential tagging of rna for preparation of a cell-free dna/rna sequencing library |
US20200149036A1 (en) * | 2017-01-02 | 2020-05-14 | Exosome Diagnostics, Inc. | Methods to distinguish rna and dna in a combined preparation |
WO2020142153A1 (en) * | 2018-12-31 | 2020-07-09 | Htg Molecular Diagnostics, Inc. | Methods of detecting dna and rna in the same sample |
CN113518829A (zh) * | 2018-12-31 | 2021-10-19 | Htg分子诊断有限公司 | 检测同一样品中dna和rna的方法 |
CN110093455A (zh) * | 2019-04-27 | 2019-08-06 | 中国医学科学院病原生物学研究所 | 一种呼吸道病毒的检测方法 |
CN111139532A (zh) * | 2020-02-24 | 2020-05-12 | 南京诺唯赞生物科技有限公司 | 一种dna和rna同时构建测序文库的方法及试剂盒 |
CN111188094A (zh) * | 2020-02-24 | 2020-05-22 | 南京诺唯赞生物科技有限公司 | 一种用于病原微生物检测的测序文库构建方法和试剂盒 |
CN111471676A (zh) * | 2020-03-13 | 2020-07-31 | 广州市达瑞生物技术股份有限公司 | 一种宏基因组二代测序的建库样本的制备方法 |
CN114075596A (zh) * | 2020-08-12 | 2022-02-22 | 深圳华大因源医药科技有限公司 | 一种基于高通量测序技术检测目的微生物基因组rna的方法 |
CN112195521A (zh) * | 2020-09-11 | 2021-01-08 | 翌圣生物科技(上海)有限公司 | 一种基于转座酶的dna/rna共建库方法、试剂盒及应用 |
CN112011596A (zh) * | 2020-09-11 | 2020-12-01 | 深圳华大因源医药科技有限公司 | 一种同时检测多种微生物基因组的方法、溶液和试剂盒 |
CN112176420A (zh) * | 2020-09-15 | 2021-01-05 | 上海英基生物科技有限公司 | 一种dna和rna共建库的方法及试剂盒 |
CN112226488A (zh) * | 2020-10-13 | 2021-01-15 | 上海宝藤生物医药科技股份有限公司 | 一种基于总核酸和宏基因组学构建病原微生物测序文库的方法及试剂盒 |
CN112011835A (zh) * | 2020-10-22 | 2020-12-01 | 南京实践医学检验有限公司 | 一种病原微生物检测用测序文库的构建方法 |
CN112680795A (zh) * | 2020-12-29 | 2021-04-20 | 上海派森诺生物科技股份有限公司 | 一种mNGS法检测病原微生物的DNA文库构建方法 |
CN112646859A (zh) * | 2020-12-30 | 2021-04-13 | 中国人民解放军疾病预防控制中心 | 一种基于宏基因组学的呼吸道咽拭子样本的建库方法和病原检测方法 |
CN113249439A (zh) * | 2021-05-11 | 2021-08-13 | 杭州圣庭医疗科技有限公司 | 一种简化dna甲基化文库及转录组共测序文库的构建方法 |
CN113355390A (zh) * | 2021-06-04 | 2021-09-07 | 翌圣生物科技(上海)股份有限公司 | 可区分dna和rna来源的共建库方法 |
CN113215235A (zh) * | 2021-06-17 | 2021-08-06 | 嘉兴允英医学检验有限公司 | 一种高通量快速检测病原微生物的方法 |
CN113684249A (zh) * | 2021-08-25 | 2021-11-23 | 广州达安基因股份有限公司 | 一种rna和dna二代测序文库的构建方法及二代测序盒 |
Non-Patent Citations (3)
Title |
---|
GORDON D HOOPLE: "Gel-seq: whole-genome and transcriptome sequencing by simultaneous low-input DNA and RNA library preparation using semi-permeable hydrogel barriers", 《LAB CHIP .》, vol. 17, no. 15, pages 2919 - 2630 * |
JASON A REUTER: "Simul-seq: combined DNA and RNA sequencing for whole-genome and transcriptome profiling", 《NAT METHODS .》, vol. 13, no. 11, pages 953 - 958, XP055597677, DOI: 10.1038/nmeth.4028 * |
万睿璇: "单细胞基因组和转录组的共测定方法研究进展", 《中国现代应用药学》, vol. 35, no. 9, pages 1423 - 1430 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024104216A1 (zh) * | 2022-11-14 | 2024-05-23 | 南京诺唯赞生物科技股份有限公司 | 一种dna和rna混合物的处理方法 |
Also Published As
Publication number | Publication date |
---|---|
CN117025723A (zh) | 2023-11-10 |
WO2024104216A1 (zh) | 2024-05-23 |
CN115747208B (zh) | 2023-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8846347B2 (en) | Sequence tag directed subassembly of short sequencing reads into long sequencing reads | |
US20230056763A1 (en) | Methods of targeted sequencing | |
CN113444770B (zh) | 一种单细胞转录组测序文库的构建方法及其应用 | |
EP3907296A1 (en) | Gene target region enrichment method and kit | |
WO2024104216A1 (zh) | 一种dna和rna混合物的处理方法 | |
CN117551746B (zh) | 一种检测目标核酸及其邻近区域核酸序列的方法 | |
CN111575348A (zh) | 宏基因组文库及建库方法和应用 | |
CN118272508A (zh) | 基于单端接头转座酶的单细胞基因组测序试剂盒及其应用 | |
US11987837B2 (en) | Nucleic acid sequence enrichment by defined nucleic acid-directed endonuclease digestion | |
CN110951827A (zh) | 一种转录组测序文库快速构建方法及其应用 | |
CN112080555A (zh) | Dna甲基化检测试剂盒及检测方法 | |
CN112680794A (zh) | 一种应用于ngs平台的超微量核酸样本建库方法 | |
WO2020135650A1 (zh) | 一种基因测序文库的构建方法 | |
CN108265047B (zh) | 用于dna片段的非特异性复制的方法及试剂盒 | |
CN114836415B (zh) | 一种mgi平台转座酶双端标签文库的制备 | |
WO2022094863A1 (zh) | 一种全转录组水平rna结构检测方法及其应用 | |
CN114774514B (zh) | 一种适用于高通量靶向基因组甲基化检测的文库构建方法及其试剂盒 | |
CN116463398B (zh) | 一种与鸡核糖体rna结合的特异性探针组及应用 | |
CN113005178B (zh) | 一种rna文库的构建方法及试剂盒 | |
EP3571316B1 (en) | Method for normalizing a nucleic acid sample | |
US20230122979A1 (en) | Methods of sample normalization | |
CN117821561A (zh) | 基于二代测序的文库及其构建方法和试剂 | |
CN114438168A (zh) | 一种全转录组水平rna结构检测方法及其应用 | |
CN118638967A (zh) | 一种逆转录引物及其在rna病毒纳米孔高通量测序文库构建中的应用 | |
CN117721178A (zh) | 一种基于dsn构建微生物测序文库的方法与试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230719 Address after: 210046 floors 1-6, east section, building C1-2, Hongfeng Science Park, Kechuang Road, Nanjing Economic and Technological Development Zone, Nanjing, Jiangsu Province Applicant after: Nanjing novozan Biotechnology Co.,Ltd. Applicant after: Nanjing nuoweizan animal health Co.,Ltd. Address before: 210046 floors 1-6, east section, building C1-2, Hongfeng Science Park, Kechuang Road, Nanjing Economic and Technological Development Zone, Nanjing, Jiangsu Province Applicant before: Nanjing novozan Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |